(NASDAQ: GHRS) Gh Research's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 69.56%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 39.96%.
Gh Research's earnings in 2026 is -$42,923,000.On average, 11 Wall Street analysts forecast GHRS's earnings for 2026 to be -$104,482,313, with the lowest GHRS earnings forecast at -$187,229,526, and the highest GHRS earnings forecast at -$51,453,383. On average, 9 Wall Street analysts forecast GHRS's earnings for 2027 to be -$114,245,740, with the lowest GHRS earnings forecast at -$172,640,212, and the highest GHRS earnings forecast at -$54,709,926.
In 2028, GHRS is forecast to generate -$125,485,466 in earnings, with the lowest earnings forecast at -$217,623,929 and the highest earnings forecast at -$25,401,037.